Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Validated in vitro assay - the MTT Time Course Assay using the EpiDerm™ Skin Model (cited in OECD 439); GLP study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010
Report date:
2010

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
The EpiDerm™ Skin Model was used to assess the dermal irritation potential of the substance. Reduction of MTT dye to a blue precipitate was used to
assess cellular metabolism after exposure to the test article for various exposure times. The time of exposure resulting in a 50% decrease in MTT
conversion (ET50) in test article-treated EpiDerm™ cultures, relative to control cultures, was determined.
GLP compliance:
yes
Remarks:
FDA, EPA, OECD

Test material

Constituent 1
Reference substance name:
N,N'-bis[2-hydroxy-3-(2,2,3,3- tetrafluoropropoxy)propyl]-N,N,N',N'-tetramethylethane-1,2- diaminium dichloride
IUPAC Name:
N,N'-bis[2-hydroxy-3-(2,2,3,3- tetrafluoropropoxy)propyl]-N,N,N',N'-tetramethylethane-1,2- diaminium dichloride
Constituent 2
Chemical structure
Reference substance name:
1,1,2,2,17,17,18,18-octafluoro-6,13-dihydroxy-8,8,11,11-tetramethyl-4,15-dioxa-8,11-diazaoctadecane-8,11-diium dichloride
EC Number:
700-737-4
Cas Number:
1220100-43-5
Molecular formula:
C18H34F8N2O4.2Cl
IUPAC Name:
1,1,2,2,17,17,18,18-octafluoro-6,13-dihydroxy-8,8,11,11-tetramethyl-4,15-dioxa-8,11-diazaoctadecane-8,11-diium dichloride
Details on test material:
- Physical state: Solid, white
- Storage condition of test material: Room temperature, protected from light

Test animals

Species:
other: Not applicable
Strain:
other: Not applicable

Test system

Details on study design:
The EpiDermTM cultures were treated in duplicate with the test article at four exposure times of 4, 8, 16, and 24 hours. The positive control, 1% Triton®-X-100, was also exposed in duplicate for 4 and 8 hours. The negative control was exposed in duplicate for 4 and 24 hours.

Results and discussion

In vivo

Irritant / corrosive response data:
After 24 hours more than 50% of the cells (54.6%) treated with the test substance remained viable indicating the ET50 was greater than 24 hours, reflective of a very low order of skin irritation potential. The ET50 of the positive control was 5.83 hours, in the range of historical control values.

Any other information on results incl. tables

ET50 Data

Test Substance ET50 (hours) = > 24 hrs

Positive Control ET50 (hours) = 5.83 hrs

Applicant's summary and conclusion

Interpretation of results:
other: Very low order of skin irritation potential
Conclusions:
The ET50 result collected on the test article did not cause > 50 % relative toxicity to the tissues up to the longest prescribed exposure time of 24 hours (ET50 > 24 hours). This is indicative of a very low order of skin irritation potential.
Executive summary:

The EpiDerm™ Skin Model was used to assess the dermal irritation potential of the test substance. Reduction of MTT dye to a blue precipitate was used to assess cellular metabolism after exposure to the test article for various exposure times. The time of exposure resulting in a 50% decrease in MTT conversion (ET50) in test article-treated EpiDerm™ cultures, relative to control cultures, was determined.

The EpiDermTMcultures were treated in duplicate with the test article at four exposure times of 4, 8, 16, and 24 hours. The positive control, 1% Triton®-X-100, was also exposed in duplicate for 4 and 8 hours. After 24 hours more than 50% of the cells (54.6%) treated with the test substance remained viable indicating the ET50was greater than 24 hours, reflective of a very low order of skin irritation potential.

The ET50of the positive control was 5.83 hours, in the range of historical control values.